Market Overview

Raymond James Downgrades Red Hat Ahead Of Q1 Print

Raymond James Downgrades Red Hat Ahead Of Q1 Print

Heading into Thursday's earnings report, investors should no longer be bullish on Red Hat Inc (NYSE: RHT), according to Raymond James.

The Analyst

Raymond James' Michael Turits downgraded Red Hat from Outperform to Market Perform with no assigned price target (prior price target of $166).

The Thesis

Raymond James' first-hand checks with U.S. and European Value Added Resellers (VARs) were "mostly strong" in the first quarter, Turits said in a note. The checks also echoed the company's own warnings that legacy middleware is slowing as applications move to containers and the cloud. As such, there's now lower visibility into growth this year which also adds pressure on the company's other emerging technologies to maintain high levels of growth.

Meanwhile, Red Hat faces risks related to its margins and top-line with a shift in focus to mid-market in 2018, the analyst said. While not unique to Red Hat, investors shouldn't ignore foreign exchange concerns after the euro lost 6 percent in value since the company's fourth-quarter report.

Given multiple company-specific and macro trends ahead, the stock's current peak valuation of 31 times on fiscal 2019 estimated EV/FCF implies a neutral risk-reward profile with a bull-case scenario offering investors a 15 percent return and a bear-case scenario would send shares lower by 15 percent.

Price Action

Shares of Red Hat were trading lower by more than 3 percent Tuesday at $170.78.

Related Links:

Cloud Confusion: Wall Street's Mixed Reaction To Red Hat's Q4

Nomura: Red Hat Could Have $66 Billion Total Addressable Market By 2020

Latest Ratings for RHT

Jul 2019SuspendsNot Rated
Jun 2019DowngradesOutperformMarket Perform
Nov 2018DowngradesOverweightSector Weight

View More Analyst Ratings for RHT
View the Latest Analyst Ratings

Posted-In: cloud Michael Turits Middleware Raymond JamesAnalyst Color Downgrades Analyst Ratings Best of Benzinga


Related Articles (RHT)

View Comments and Join the Discussion!

Latest Ratings

View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at

Mid-Afternoon Market Update: Crude Oil Down 1.5%; Sarepta Shares Spike Higher

Analyst: Sarepta's DMD Gene Therapy Results 'Dramatic And Far Exceeding Expectations'